肺動脈瓣置換器，經皮植入
PMA 核准號：P200046 · 2026-06-01
廣告
器材摘要
Pulmonary valve prosthesis percutaneously delivered is the device name listed in this FDA 510(k) record. The listed applicant is Medtronic, Inc.. It received FDA 510(k) clearance on 2026-06-01. The device is classified under product code NPV. It was reviewed by the CV advisory panel.
常見問題
What is the Pulmonary valve prosthesis percutaneously delivered?
Pulmonary valve prosthesis percutaneously delivered is a medical device that received FDA 510(k) clearance on 2026-06-01. The listed applicant is Medtronic, Inc..
When did Pulmonary valve prosthesis percutaneously delivered receive FDA 510(k) clearance?
The clearance date for Pulmonary valve prosthesis percutaneously delivered can be found in the official FDA records.
誰是經皮植入肺動脈瓣置換器的登記申請人？
FDA 510(k) 記錄將美敦力公司（Medtronic, Inc.）列為申請人。這並不單獨確立該設備製造商。
FDA肺動脈瓣置換器經皮植入的產品代碼是什麼？
FDA對經皮植入肺動脈瓣的產品代碼為NPV。
相關臨床試驗
相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。
官方來源
在 FDA 資料庫中查看 →資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。
廣告